Bayer Radiology as the worldwide market leader in diagnostic imaging, continues to drive forward innovation in CT & MRI. We are providing Ultravist®, a guideline changing, quality & safety proven contrast media with up to date clinical data for CT and X-ray, Gadovist® 1.0, 1.0 M MRI contrast agent with high relaxivity and safety-proven data for all ages (incl. neonate) & whole body indication and Primovist®, an outstanding liver specific MRI contrast medium.
Now with the new business model from Bayer Radiology, we are continuously evolving our portfolio: including contrast media, we are expanding our business with medical devices thriving to become ‘The Solution Provider’.
Guerbet is a pharmaceutical group specialized in medical imaging providing contrast media for diagnostic purposes. The company’s origin is linked to Marcel Guerbet’s discovery of the first organic iodinated contrast medium in 1901, Lipiodol®.
The Guerbet company was created in 1926 by André Guerbet. Since then, the company’s significant growth has been driven by regular innovations in medical imaging technologies accompanied by the introduction of new contrast media.
Over the last 40 years, Guerbet’s own research and development resulted in the launching of four major products: Telebrix®, Hexabrix®, Dotarem® and Xenetix®
And Guerbet successfully launch CT injector, Flowsens®
Dongkook Lifescience. Co,. Ltd. is a specialized pharmaceutical company for diagnostic medicine and medical device. We are providing the most widely used Iopamidol product(Pamiray®) in Korea. Also, we exported contrast media to EU and Japan about 30 million US dollar in 2019.
Dongkook Lifescience promises to strive to have competitive power in order to be a reliable corporate of domestic and foreign customer.
Our company motto is creation, harmony and trust. Creation means the origination of higher value added by development of the individual’s abilities. Harmony means the harmonious teamwork of these abilities. Based on the principal above, the things gain from the fulfillment of customer expectation is the trust. In addition, our final goal – respect for life and healthy life of the nation – settled the policy of the company, Human & Life.
United Imaging Healthcare Co. Ltd. (“UIH”) which is dedicated to providing, developing and producing high-performance advanced medical imaging, radiotherapy equipment, life science instruments and offers intelligent digital solutions to customers worldwide. UIH was founded in 2011 and headquartered in Shanghai, and has subsidiaries and R&D centers across China, the United States.
UIH has a world-class talent team including more than 140 scientists with global experience and more than 500 employees with rich R&D and management experience in the medical industry. And 35% of 6,000 employees are R&D personnel.
UIH has launched over 110 ground-breaking products, including Total-Body PET/CT, HD TOF PET/MR, 75cm Ultra-Wide Bore 3.0T MR, 640-Slice CT Scanner, and Fully Integrated CT-linac. All core technologies are developed in house and have been globally or nationally recognized for world-leading performance.
UIH products have been installed in more than 8,700 medical and research institutes and nearly 900 top hospitals in 44 countries, including the U.S. and Japan. UIH topped China’s new market share lists in the PET/CT, PET/MR, MR, CT and Mobile DR sector in 2020.
- A private-capital Italian multinational in life sciences, the Bracco Group operates through its four business units: Imaging, ACIST Medical Systems, Pharma, and Health Services.
- Headquartered in Milan, Italy, Bracco Imaging S.p.A. is one of the world's leading companies in the diagnostic imaging business. Bracco Imaging provides a diverse portfolio of imaging agents, which are products used during diagnostic imaging procedures to enhance the anatomical and functional visualization of internal body organs and areas. Additionally, it operates in over 90 markets worldwide, either directly or indirectly through subsidiaries, joint ventures, license and distribution partnership agreements.
- As a new business unit of Bracco Imaging, Bracco Injeneering S.A. offers quality contrast delivery solutions for state-of-the-art radiology centers, providing proven injection technology. Bracco Imaging Korea, a fully owned subsidiary of Bracco Imaging, markets Iomeron® and Iopamiro® (two non-ionic monomeric iodinated agents for CT and cardiology), MultiHance® (a high relaxivity agent for liver), ProHance® (a Macrocyclic MRI agent), and SonoVue® (a contrast agent for ultrasound exams). Moreover, Bracco Imaging Korea supplies EmpowerCTA® (CT injector), EmpowerMR® (MR injector), and CT Exprès™ through a local distributor.
- We pioneer breakthroughs in healthcare. For everyone. Everywhere.
- Siemens Healthineers Ltd. enables healthcare providers worldwide to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving patient experience and digitalizing healthcare.
- A leader in medical technology, Siemens Healthineers is constantly innovating its portfolio of products and services in its core areas of diagnostic and therapeutic imaging and in laboratory diagnostics and molecular medicine. Siemens Healthineers is also actively developing its digital health services and enterprise services.
Further information is available https://www.siemens-healthineers.com/kr/.
- SIGNA™ MR enhances your MRI capabilities with efficient workflow and productivity solutions for routine scanning and brings innovation for advanced clinical procedures, all while keeping patient satisfaction at the forefront.
- Philips has shaped the future of healthcare since 1891 in the belief that there is always a way to make life better.
- From CT and MR to Ultrasound, X-ray and IGT, our entire imaging portfolio aims to give care providers the right image at the right time, to support a faster, more confident diagnosis.
- We also have helped our customers solve complex challenges, identify new opportunities and create future-ready solutions. We are driven to help our customers achieve its goals—technical, clinical and business—today and for years to come.
https://www.philips.co.kr/.